Here's how YOU could get a Covid booster jab this summer – find out if you’re eligible

BRITS can get a Covid booster jab this summer thanks to a world-first trial launching in the UK.

A new clinical trial looking at the effect of seven different vaccines on immune responses starts today – to help protect the most vulnerable this winter.

🔵 Read our coronavirus live blog for the latest updates

If you are over 30 and have had both Covid jabs, then you can sign up to be a potential participant in the groundbreaking study.

Vaccines being trialled are the Oxford/AstraZeneca, Pfizer/BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac, as well as a control group

The Cov-Boost study, led by University Hospital Southampton NHS Foundation Trust and backed by £19.3 million of government funding, is the first in the world to test out boosters.

It will include a total of 2,886 patients and participants will start being vaccinated from early June.

It comes as:

  • Fury as ‘red list’ passengers forced to mix with green listers as airport closures spark ‘super-spreader’ mixing
  • Indian variant cases ‘concentrated in school age kids and young adults’ who haven’t been jabbed
  • Flights from India STILL landing in UK with 1,000 passengers arriving today and 110 planes since country put on red list
  • Sewage could be used to see if YOUR area will be plunged into local lockdown amid Indian variant
  • Brits warned to ‘ration’ hugs amid Indian variant spread fears

The study will have 16 sites based across England, Wales and Scotland.

Initial findings, expected in September, will help the Joint Committee on Vaccination and Immunisation (JCVI) decide on booster programme plans.

Everyone involved will be monitored throughout the study for any side effects and will have bloods taken to measure their immune responses at days 28, 84, 308 and 365.

All sites will have an electronic diary for all participants that will send alerts to the team in real time if needed and a 24-hour emergency phone to a doctor on the study, who can provide further clinical advice.

The UK has secured 517 million vaccine doses:

  • Pfizer/BioNTech for 100 million doses – including the additional 60 million doses for the booster programme
  • Oxford/AstraZeneca for 100 million doses
  • Moderna for 17 million doses
  • Janssen for 30 million doses
  • Novavax for 60 million doses
  • Valneva for 100 million doses
  • GlaxoSmithKline and Sanofi Pasteur for 60 million doses
  • CureVac for 50 million doses 

Health and Social Care Secretary, Matt Hancock said: “The UK vaccination programme has been a phenomenal national effort, with seven in 10 UK adults now having had their first Covid-19 jab. It is vital that we continue to support the world-renowned British research sector that has contributed to its success.

“We will do everything we can to future-proof this country from pandemics and other threats to our health security, and the data from this world-first clinical trial will help shape the plans for our booster programme later this year.

“I urge everyone who has had both doses of a Covid-19 vaccine, and is eligible, to sign up for this study and play a part in protecting the most vulnerable people in this country and around the world for months and years to come.”

The trial will look at seven different Covid-19 vaccines as potential boosters, given at least 10 to 12 weeks after a second dose as part of the ongoing vaccination programme.

One booster will be provided to each volunteer and could be a different brand to the one they were originally vaccinated with.

Sign up here to be involved and see if you are selected.

Minister for Covid-19 Vaccine Deployment Nadhim Zahawi said: “With over 57 million vaccines administered since the beginning of the rollout, the programme continues its fantastic trajectory.

“Having taken part in a Covid-19 vaccine clinical trial myself, I would encourage everyone eligible to volunteer – whatever your religion, ethnicity or background, it’s a fantastic opportunity to get involved with such an historic initiative.” 


 

    Source: Read Full Article